Literature DB >> 10516473

Hepatitis E virus. Advances in HEV biology and HEV vaccine approaches.

P O Yarbough1.   

Abstract

Hepatitis E, previously known as enterically transmitted, enteric, or epidemic hepatitis, is a worldwide public health problem. The causative agent, the hepatitis E virus, is involved in epidemic, sporadic, and fulminant hepatitis cases worldwide. This review describes the advances in the biology of the hepatitis E virus and the progress made to develop simple and robust serologic assays for the diagnosis of HEV infection. Genomic sequence comparisons with a recently identified US isolate now suggests three genetic groups of HEV viruses. A highly conserved animal isolate found in pigs suggest the coexistence of animal and human isolates of HEV. The use of recombinant technology to develop an effective subunit vaccine capable of providing cross-protection for the most divergent HEV strains has been established and is reviewed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10516473     DOI: 10.1159/000024978

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  9 in total

Review 1.  Nonhuman Primate Models of Hepatitis A Virus and Hepatitis E Virus Infections.

Authors:  Robert E Lanford; Christopher M Walker; Stanley M Lemon
Journal:  Cold Spring Harb Perspect Med       Date:  2019-02-01       Impact factor: 6.915

2.  Hepatitis E virus immunoglobulin G antibodies in different populations in Campinas, Brazil.

Authors:  N S Gonçales; J R Pinho; R C Moreira; C P Saraceni; A M Spina; R B Stucchi; A D Filho; L A Magna; F L Gonçales Júnior
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

Review 3.  Hepatitis E: an overview and recent advances in vaccine research.

Authors:  Ling Wang; Hui Zhuang
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

Review 4.  Hepatitis E virus: Current epidemiology and vaccine.

Authors:  Xing Wu; Pan Chen; Huijuan Lin; Xiaotian Hao; Zhenglun Liang
Journal:  Hum Vaccin Immunother       Date:  2016-05-16       Impact factor: 3.452

Review 5.  Hepatitis E vaccines: progress and prospects.

Authors:  Harald Claus Worm; Gerhard Wirnsberger
Journal:  Drugs       Date:  2004       Impact factor: 9.546

6.  Seroprevalence of anti-hepatitis E virus (HEV) in a Korean population: comparison of two commercial anti-HEV assays.

Authors:  Hyun Kyung Park; Sook-Hyang Jeong; Jin-Wook Kim; Byung-Hyun Woo; Dong Ho Lee; Hyun Young Kim; Soyeon Ahn
Journal:  BMC Infect Dis       Date:  2012-06-22       Impact factor: 3.090

Review 7.  Vaccine Development against Zoonotic Hepatitis E Virus: Open Questions and Remaining Challenges.

Authors:  Yuchen Nan; Chunyan Wu; Qin Zhao; Yani Sun; Yan-Jin Zhang; En-Min Zhou
Journal:  Front Microbiol       Date:  2018-02-19       Impact factor: 5.640

Review 8.  [Vaccines against hepatitis E virus: state of development].

Authors:  Patrick Behrendt; Heiner Wedemeyer
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2022-01-31       Impact factor: 1.513

9.  Effective inhibition of hepatitis E virus replication in A549 cells and piglets by RNA interference (RNAi) targeting RNA-dependent RNA polymerase.

Authors:  Fen Huang; Xiuguo Hua; Shixing Yang; Congli Yuan; Wen Zhang
Journal:  Antiviral Res       Date:  2009-07-01       Impact factor: 5.970

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.